Gland Pharma Q2 Results | Net profit falls 16% to ₹164 crore, R&D expenses at ₹49 crore
Gland Pharma Q2 Results | Revenue from operations increased 2.4% to ₹1,405.8 crore. Shares of Gland Pharma Ltd ended at ₹1,602.35, down by ₹42.50, or 2.58%, on the BSE.

What's Your Reaction?






